Yet, individual responses to supplements may differ
Primary carnitine deficiency PCD is a rare genetic disease caused by mutations in the SLC22A5 gene, which leads to dysfunction of the carnitine transporter OCTN2, thereby hindering the entry of carnitine from the blood into cells and the reabsorption of carnitine by the kidneys
Instead, AOD-9604 mimics the metabolic benefits of hGH while reducing concerns over potential long-term side effects, such as insulin resistance or excessive tissue growth
Semaglutide is the superior **fat loss peptide injection** by every meaningful clinical metric: - **~15x more clinical participants studied** (20,000+ vs ~500) - **Statistically significant weight loss** vs AOD-9604's failed trial - **FDA approval** vs Category 2 restriction - **Cardiovascular benefits** vs no outcomes data - **Once-weekly dosing** vs daily injections - **Long-term maintenance data** vs none For anyone searching for **AOD-9604 results** or **AOD-9604 alternatives**, the evidence clearly points toward GLP-1 **peptide injections for weight loss** as the superior choice
Not because these medications are inherently harmful, but because any powerful metabolic intervention deserves thoughtful oversight
